Skip to main content
. 2019 Dec 20;39(12):1443–1452. [Article in Chinese] doi: 10.12122/j.issn.1673-4254.2019.12.08

2.

2

肝癌患者不同DNMT3B表达程度的肿瘤无瘤生存率与肿瘤特异性生存率

Tumor-free survival rate and tumor-specific survival rate of HCC patients with different levels of DNMT3B expression. A: Recurrence-free survival; B: Disease-specific survival.